Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors
Viruses · 2023
DOI: 10.3390/v15122291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Behnaz Yazdani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), 08500 Vic, Spain. Hauptthemen laut MEDLINE: COVID-19, Molecular Dynamics Simulation, Coronavirus Protease Inhibitors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bioinformatics Research Center in Isfahan University of 550 Medical Sciences, Isfahan, Iran, Bioinformatics Research Center in Isfahan University of Medical Sciences, Isfahan.
Abstract (Originalsprache)
Since the emergence of SARS-CoV-2, many genetic variations within its genome have been identified, but only a few mutations have been found in nonstructural proteins (NSPs). Among this class of viral proteins, NSP3 is a multidomain protein with 16 different domains, and its largest domain is known as the macrodomain or Mac1 domain. In this study, we present a virtual screening campaign in which we computationally evaluated the NCI anticancer library against the NSP3 Mac1 domain, using Molegro Virtual Docker. The top hits with the best MolDock and Re-Rank scores were selected. The physicochemical analysis and drug-like potential of the top hits were analyzed using the SwissADME data server. The binding stability and affinity of the top NSC compounds against the NSP3 Mac1 domain were analyzed using molecular dynamics (MD) simulation, using Desmond software, and their interaction energies were analyzed using the MM/GBSA method. In particular, by applying subsequent computational filters, we identified 10 compounds as possible NSP3 Mac1 domain inhibitors. Among them, after the assessment of binding energies (ΔGbind) on the whole MD trajectories, we identified the four most interesting compounds that acted as strong binders of the NSP3 Mac1 domain (NSC-358078, NSC-287067, NSC-123472, and NSC-142843), and, remarkably, it could be further characterized for developing innovative antivirals against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), 08500 Vic, Spain.
- Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
ORCID-Profile: Behnaz Yazdani, Hajar Sirous, Simone Brogi
Förderung
- Bioinformatics Research Center in Isfahan University of 550 Medical Sciences, Isfahan, Iran
- Bioinformatics Research Center in Isfahan University of Medical Sciences, Isfahan
Zitieren
APA
Yazdani, B., Sirous, H., Brogi, S., & Calderone, V. (2023). Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. Viruses. https://doi.org/10.3390/v15122291
Vancouver
Yazdani B, Sirous H, Brogi S, Calderone V. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. Viruses. 2023. doi:10.3390/v15122291
BibTeX
@article{Yazdani2023,
author = {Yazdani, Behnaz and Sirous, Hajar and Brogi, Simone and Calderone, Vincenzo},
title = {Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122291}
}
EUVIMED